ZA200004909B - Lipophilic microparticles containing a protein drug or antigen and formulation comprising same. - Google Patents

Lipophilic microparticles containing a protein drug or antigen and formulation comprising same.

Info

Publication number
ZA200004909B
ZA200004909B ZA200004909A ZA200004909A ZA200004909B ZA 200004909 B ZA200004909 B ZA 200004909B ZA 200004909 A ZA200004909 A ZA 200004909A ZA 200004909 A ZA200004909 A ZA 200004909A ZA 200004909 B ZA200004909 B ZA 200004909B
Authority
ZA
South Africa
Prior art keywords
antigen
formulation
same
protein drug
microparticles containing
Prior art date
Application number
ZA200004909A
Inventor
Myung Jin Kim
Sun Jin Kim
Kyu Chan Kwon
Joon Kim
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of ZA200004909B publication Critical patent/ZA200004909B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200004909A 1999-01-18 2000-09-14 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same. ZA200004909B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990001232A KR100329336B1 (en) 1999-01-18 1999-01-18 Hyaluronate microparticles for sustained release of a protein drug

Publications (1)

Publication Number Publication Date
ZA200004909B true ZA200004909B (en) 2001-09-14

Family

ID=19571551

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200004909A ZA200004909B (en) 1999-01-18 2000-09-14 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same.

Country Status (2)

Country Link
KR (1) KR100329336B1 (en)
ZA (1) ZA200004909B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426636B1 (en) * 2001-05-18 2004-04-08 한국과학기술연구원 Injectable Gel Type Lipid Composition And Preparation Method Thereof
KR101805087B1 (en) 2010-09-16 2017-12-05 주식회사 엘지화학 Non-aqueous Oily Injectable Formulation Exhibiting Preservative Efficacy
WO2013183948A1 (en) 2012-06-05 2013-12-12 씨제이제일제당 (주) Highly glycosylated long-acting human growth hormone protein and production method for same
KR102183941B1 (en) * 2019-11-22 2020-11-27 주식회사 지씨에스 Injectable formulation containing a poly l lactic acid filler and a hyaluronic acid filler conjugate and a method for preparing the same
KR102184198B1 (en) * 2019-11-22 2020-11-30 주식회사 지씨에스 Sustained release injectable formulation containing a poly l lactic acid filler, a hyaluronic acid filler conjugate, and a bioactive material, and a method for preparing the same

Also Published As

Publication number Publication date
KR20000051004A (en) 2000-08-16
KR100329336B1 (en) 2002-03-22

Similar Documents

Publication Publication Date Title
HK1036415A1 (en) Lipophilic microparticles containing a protein drug or antigen and formulation comprising same.
EP1073490A4 (en) Improved drug delivery device and methods therefor
HUP0103793A3 (en) N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them
AP9801173A0 (en) Rapidly releasing and taste-making pharmaceutical dosage
HK1079215A1 (en) 17 alpfa-alkyl-17beta-oxy-estrqatrienes, uses thereof and pharmaceutical preparations
IL143580A0 (en) Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
AU2002241538A1 (en) Intrasvascular drug delivery device and use therefor
DE69814091D1 (en) PRE-ICONAZOLE CONTAINING PHARMACEUTICAL PREPARATIONS
HK1020949A1 (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
HUP0202781A3 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
IL149209A0 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
CZ2000522A3 (en) Pharmaceutical preparation based on piperidinalkanol antihistaminic and use thereof
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
GB9714750D0 (en) Drug delivery device
ZA200004909B (en) Lipophilic microparticles containing a protein drug or antigen and formulation comprising same.
HUP0201478A3 (en) Neuroprotective and retinoprotective ophthalmologic medicines
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.
ZA982851B (en) Pharmaceutical formulation comprising Tyrosine and DMPL.
EP1154783A4 (en) Medicaments comprising relaxin and their use
AU6269901A (en) Biologically active agents and drugs
AU2001262699A1 (en) Biologically active agents and drugs
MXPA01011611A (en) Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them.
HUP0002905A3 (en) 2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use